$397.23 Million in Sales Expected for Medical Properties Trust, Inc. (NYSE:MPW) This Quarter

Analysts predict that Medical Properties Trust, Inc. (NYSE:MPW) will announce $397.23 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Medical Properties Trust’s earnings. The highest sales estimate is $415.15 million and the lowest is $372.49 million. Medical Properties Trust posted sales of $333.81 million in the same quarter last year, which would indicate a positive year over year growth rate of 19%. The firm is scheduled to announce its next earnings report on Thursday, February 3rd.

According to Zacks, analysts expect that Medical Properties Trust will report full year sales of $1.51 billion for the current fiscal year, with estimates ranging from $1.34 billion to $1.57 billion. For the next financial year, analysts expect that the firm will report sales of $1.66 billion, with estimates ranging from $1.56 billion to $1.72 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that cover Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last announced its earnings results on Thursday, October 28th. The real estate investment trust reported $0.29 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.44 by ($0.15). Medical Properties Trust had a net margin of 38.08% and a return on equity of 6.90%. The business had revenue of $390.78 million for the quarter, compared to analyst estimates of $387.24 million. During the same period in the prior year, the company earned $0.41 earnings per share. The company’s quarterly revenue was up 18.6% on a year-over-year basis.

Several brokerages recently issued reports on MPW. Bank of America raised Medical Properties Trust from a “neutral” rating to a “buy” rating and upped their target price for the company from $21.50 to $24.00 in a research report on Wednesday, October 27th. Raymond James upped their target price on Medical Properties Trust from $25.00 to $26.00 and gave the company a “strong-buy” rating in a research report on Friday, October 29th. Zacks Investment Research lowered Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Thursday, August 5th. Finally, Royal Bank of Canada raised Medical Properties Trust from a “sector perform” rating to an “outperform” rating and set a $23.00 price objective on the stock in a report on Wednesday, August 11th. They noted that the move was a valuation call. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Medical Properties Trust has a consensus rating of “Buy” and a consensus price target of $24.00.

NYSE:MPW traded up $0.51 during mid-day trading on Thursday, hitting $22.10. 3,223,896 shares of the company’s stock traded hands, compared to its average volume of 4,094,886. The company has a fifty day moving average of $20.86 and a 200 day moving average of $20.76. Medical Properties Trust has a twelve month low of $19.32 and a twelve month high of $22.82. The company has a market capitalization of $13.18 billion, a P/E ratio of 23.02, a P/E/G ratio of 1.61 and a beta of 0.48. The company has a debt-to-equity ratio of 1.27, a quick ratio of 3.77 and a current ratio of 3.77.

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 13th. Stockholders of record on Thursday, December 9th will be paid a $0.28 dividend. The ex-dividend date of this dividend is Wednesday, December 8th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 5.07%. Medical Properties Trust’s payout ratio is 116.67%.

A number of hedge funds have recently modified their holdings of MPW. Allworth Financial LP purchased a new position in Medical Properties Trust during the second quarter worth approximately $26,000. Dark Forest Capital Management LP purchased a new position in shares of Medical Properties Trust in the third quarter valued at approximately $26,000. Moors & Cabot Inc. purchased a new position in shares of Medical Properties Trust in the third quarter valued at approximately $27,000. Bedel Financial Consulting Inc. lifted its position in shares of Medical Properties Trust by 400.0% in the second quarter. Bedel Financial Consulting Inc. now owns 1,500 shares of the real estate investment trust’s stock valued at $30,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Penserra Capital Management LLC lifted its position in shares of Medical Properties Trust by 42.1% in the second quarter. Penserra Capital Management LLC now owns 1,876 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 556 shares in the last quarter. Institutional investors own 78.89% of the company’s stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust, which engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals; long-term acute care hospitals; ambulatory surgery centers; hospitals for women and children; regional and community hospitals; medical office buildings; and other single-discipline facilities.

Featured Story: Understanding each part of a balance sheet

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.